Abbott Laboratories

American global health care and medical device products company

ABT NYSE ISIN US0028241000 SEC CIK 1800 LEI HQD377W2YR662HK5JX27
Follow Abbott Laboratories Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $13B +14.5% vs same quarter last year
Net income $920M −44% vs same quarter last year
EPS, diluted $0.53 −43.6% vs same quarter last year
Operating cash flow $1.7B −37.7% vs same quarter last year
Revenue by quarter
$11B
$10.4B
$11.1B
$11.4B
$11.5B
$11.2B
$12.6B
$13B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$20B$40B$60BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$44.3B$6.5B
FY24$42B$13.4B
FY23$40.1B$5.7B
FY22$43.7B$6.9B
FY21$43.1B$7.1B
FY20$34.6B$4.5B
FY19$31.9B$3.7B
FY18$30.6B$2.4B
FY17$27.4B$477M
FY16$20.9B$1.4B
FY15$20.4B$4.4B
FY14$20.2B$2.3B
FY13$19.7B$2.6B
FY12$19.1B$6B
FY11$21.4B$4.7B
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2556.4%18.2%14.7%
FY2455.4%16.3%31.9%
FY2355.2%16.2%14.3%
FY2256.1%19.2%15.9%
FY2157%19.6%16.4%
FY2056.6%15.5%13%
FY1958.5%14.2%11.6%
FY1858.4%11.9%7.7%
FY1754.7%5.7%1.7%
FY1656.4%14.5%6.7%
FY1557.1%14.1%21.7%
FY1454.5%12.8%11.3%
FY1353.2%10.9%13.1%
FY1253.3%7.1%31.3%
FY1153.2%7.6%22.1%
Free cash flowOperating cash flow minus capital expenditure
$0$2.5B$5B$7.5B$10BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$7.4B
FY24$6.4B
FY23$5.1B
FY22$7.8B
FY21$8.6B
FY20$5.7B
FY19$4.5B
FY18$4.9B
FY17$4.4B
FY16$2.1B
FY15$1.9B
FY14$2.6B
FY13$2.2B
FY12$7.5B
FY11$7.5B
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$2B$4B$6B$8BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$4.1B$893M
FY24$3.8B$1.3B
FY23$3.6B$1.2B
FY22$3.3B$3.8B
FY21$3.2B$2.3B
FY20$2.6B$403M
FY19$2.3B$718M
FY18$2B$238M
FY17$1.8B$117M
FY16$1.5B$522M
FY15$1.4B$2.2B
FY14$1.3B$2.2B
FY13$882M$1.6B
FY12$3.2B$2.4B
FY11$2.9B$77M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Abbott Laboratories
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAbbott LaboratoriesHealthcare median
FY2514.7%−30.6%
FY2431.9%−47%
FY2314.3%−58%
FY2215.9%−80.4%
FY2116.4%−71.9%
FY2013%−62.2%
FY1911.6%−46.3%
FY187.7%−49.6%
FY171.7%−45.9%
FY166.7%−36%
FY1521.7%−38.4%
FY1411.3%−35.5%
FY1313.1%−37.1%
FY1231.3%−29.1%
FY1122.1%−27.9%